AUKUH-MSC response to NHS England Research and Development Strategy
30 January 2014
The Association of UK University Hospitals and the Medical Schools Council welcome the opportunity to respond to NHS England’s plans to make research “everybody’s business”. As organisations working at the interface between research, education and service delivery we welcome the vision and objectives of this strategy. To build on these strengths, our response makes the following main suggestions:
AUKUH-MSC response to Antimicrobial resistance inquiry
The Association of UK University Hospitals and Medical Schools Council welcome the opportunity to submit evidence to the Science and Technology inquiry into Antimicrobial resistance. Our response covers issues such as causes of increased resistance, gaps in our current knowledge and potential approaches to addressing this worrying threat to public health.
AUKUH is pleased to provide comments on this consultation on changes to the way CQC regulates, inspects and monitors care.
We feel that these proposals are a welcome change of approach. We welcome the clinically led focus of the new inspection plans. The peer review element of inspections is of utmost importance. Therefore, to be successful, inspection teams will need to contain clinicians with the respect of their peers. This should be an important focus in the recruitment of clinicians for inspection teams.
The AUKUH Directors of Finance group has responded to the Monitor/ NHS England discussion paper ‘How can the NHS payment system do more for patients?’
In the submission, the AUKUH group highlight the importance of stability, long-term signalling, long-term pricing mechanisms and the complexities of specialist care. It is also important that the payment systems for research, education and service are not developed in isolation from each other.
The Association of UK University Hospitals and the Medical Schools Council welcomed the opportunity to submit evidence to the Science and Technology Committee inquiry into clinical trials and the disclosure of data. Clinical trials are core business for both the AUKUH and MSC; therefore members have a keen interest in ensuring they are conducted to the highest standard with public support and engagement.